As such, lymphocyte evaluation, specially CD4, may be useful as predictor of gravity and outcome, in fact, patients with more severe clinical illness, or patients who died, had significantly more profound CD4+ lymphopenia. This evidence concerns the gene CD4 and lymphopenia.